IBB vs IJH

iShares Biotechnology ETF vs iShares Core S&P Mid-Cap ETF

Quick take
  • IJH has the lower expense ratio at 0.05% vs 0.44% for IBB.
  • IJH pays a higher dividend yield (1.22%).

Side-by-side metrics

MetricIBBIJH
Expense ratio
Annual fee. Lower is better.
0.44%0.05%
Dividend yield
Trailing 12-month yield.
0.23%1.22%
AUM
Assets under management — bigger funds are typically more liquid.
$7.95B$115.69B
YTD return
3.10%13.32%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.741.08
P/E ratio
23.7221.71
Last price
$170.10$73.66
Inception
Issuer
iSharesiShares

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

IJH top holdings

Top holdings · IJH
FLEXFlex Ltd0.98%
FTITechnipFMC PLC0.89%
CWCurtiss-Wright Corp0.78%
XPOXPO Inc0.75%
UTHRUnited Therapeutics Corp0.72%
FNFabrinet0.72%
MTZMasTec Inc0.71%
NVTnVent Electric PLC0.67%
TWLOTwilio Inc Class A0.66%
PEverpure Inc Class A0.65%
Sector breakdown · IJH
Real Estate7.5%
Consumer Cyclical10.7%
Basic Materials4.8%
Consumer Defensive3.8%
Technology15.7%
Communication Services1.0%
Financial Services14.4%
Utilities3.1%
Industrials25.0%
Energy5.5%
Healthcare8.6%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About IJH

IJH (iShares Core S&P Mid-Cap ETF) is Tracks the S&P MidCap 400 index. Managed by iShares, the fund carries $115.7B in assets under management, an expense ratio of 0.05%, a dividend yield of 1.22%. Its largest holding is Flex Ltd (FLEX), which represents 1.0% of the portfolio. Real Estate is the fund's largest sector exposure at 7.5%.